Guillaume Kulakowski

Guillaume Kulakowski has worked at a variety of companies since 2012. In that year, they completed a research internship at the EIPL laboratory (Team Canaan, UMR 7282) with the CNRS. In 2013, they completed a research internship in the Oncology department at Janssen, Pharmaceutical Companies of Johnson and Johnson. From 2014 to 2018, they worked at the Institut Curie - Research Centre, first as a PhD student (Team Molecular Mechanisms of Intracellular Transport, UMR 144) and then as a research assistant (Team Molecular Mechanisms of Intracellular Transport, UMR 144). During their time at the Institut Curie, they worked on projects related to membrane binding properties of RAB GTPases and the study of RAB6-induced membrane tethering. In 2018, they worked as a Biotechnology Consultant for Life Sciences Industries. From 2019 to 2022, they worked at Enterome as a Research Scientist - Immuno-Oncology, where they managed all in vivo preclinical studies and two laboratory technicians, and conducted in-house laboratory work such as cell culture, in vitro killing assays, ELISPOT assays, and Flow Cytometry. Currently, they are working as a Scientific Lead - Immunology for InnoSkel.

Guillaume Kulakowski began their educational journey in 2008 with undergraduate studies preparing for the entrance exams to France's elite engineering schools at Classes Préparatoires Masséna, Nice, France, studying Biology, Chemistry, Physics, and Earth Sciences. Guillaume then attended Polytech Marseille from 2010 to 2013, where they obtained an Engineering degree in Biotechnology. Finally, they completed their Doctor of Philosophy in Biology-Physics interface at Pierre and Marie Curie University from 2014 to 2017. In addition, they have obtained certifications in Experimentation Animale - Niveau Concepteur (ex Niveau I) from Sorbonne Université in March 2021, TOEFL iBT: 108/120 in July 2013, and TOEIC TEST: 985/990 in June 2012.